Longitudinal imaging of transplanted islets in a rat model with SPECT
2012-01-01 Andralojc, Km; Brom, M; Joosten, L; Bos, Dl; Oyen, W; Boerman, Oc; Gotthardt, M
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY
2019-01-01 Hurle, R; Saita, A; Lazzeri, M; Casale, P; Buffi, N; Lughezzani, G; Fasulo, V; Bevilacqua, G; Paciotti, M; Domanico, L; Maffei, D; Pasini, L; Guazzoni, G
Image quality of U-SPECT-II collimators using an adapted NEMA phantom
2012-01-01 Meeuwis, Apw; van der Have, F; Beekman, Fj; Oyen, W; Boerman, Oc; Visser, Ep
Non-invasive determination of the beta cell mass by SPECT with In-111-DTPA-exendin-3 in a rat model for spontaneous type 1 diabetes
2012-01-01 Brom, M; Bos, D; Visser, J; Joosten, L; Peeters, H; Oyen, W; Gotthardt, M; Boerman, O
Diagnostic biological imaging of early relapse
2013-01-01 Oyen, W
Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules
2013-01-01 Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, L
In-111-exendin for non-invasive quantification of beta cell mass in patients with type 1 diabetes and healthy controls
2013-01-01 van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cj; Boerman, Oc; Gotthardt, M
LAPAROSCOPIC PARTIAL NEPHRECTOMY AFTER PREVIOUS IPSILATERAL RENAL PROCEDURES
2015-01-01 Seveso, M; Castaldo, L; Hurle, R; Taverna, G; Lazzeri, M; Pasini, L; Buffi, Nm; Lughezzani, G; Casale, P; De Zorzi, Sz; Benetti, A; Guazzoni, G
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER
2019-01-01 Maffei, D; Paciotti, M; Lazzeri, M; Colombo, P; Fasulo, V; Domanico, L; Casale, P; Saita, A; Hurle, R; Buffi, N; Guazzoni, G; Lughezzani, G
Factor V Leiden is associated with premature myocardial infarction
2008-01-01 Peyvandi, F.; Spreafico, M.; Foco, L.; Bernardinelli, L.; Duga, S.; Asselta, R.; Ardissino, D.; Kathiresan, S.; Merlini, P. A.; Mannucci, P. M.
A mutational chip to detect TP53, CDKN2A and FAT1 mutations in circulating cell free-DNA of head and neck squamous cell carcinoma patients:a pilot study
2019-01-01 Ganci, F.; Spinella, F.; Cottone, G.; Cotroneo, E.; Nuccitelli, A.; Biroccio, A.; Sacconi, A.; Manciocco, V.; Pallocca, M.; Rollo, F.; Covello, R.; Benevolo, M.; Spriano, G; Fiorentino, F.; Blandino, G.
Predictive role of peritumoral CD3+infiltration and neutrophil to lymphocyte ratio on overall survial in pateints affected by colorectal liver metastases treated with chemotherapy and surgery.
2018-01-01 Cimino, M; Donadon, M; Mavilio, D; Di Tommaso, L; Roncalli, M; Hudspeth, K; Sacerdote, C; Torzilli, G
ONE STAGE HEPATECTOMY FOR MULTIPLE BILOBAR COLORECTAL LIVER METASTASES
2018-01-01 Cimino, Mm; Procopio, F; Donadon, M; Vigano, L; Del Fabbro, D; Torzilli, G
Effects of respiratory gated positron emission tomography on quantification of lesion volume and FDG uptake in clinical practice
2013-01-01 Grootjans, W; de Geus-Oei, Lf; Meeuwis, Apw; Gotthardt, M; Oyen, W; Visser, Ep
Anti-CEA antibody fragments labeled with [F-18]AlF for PET imaging of CEA-expressing tumors
2013-01-01 Franssen, Gm; Laverman, P; Chatalic, Kls; Oyen, W; Sharkey, Rm; Goldenberg, Dm; Rossi, E; Mcbride, W; Boerman, Oc
Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials
2014-01-01 Ni, W; Vriens, D; de Geus-Oei, Lf; Oyen, W; Bengtsson, T; de Crespigny, A; Sanabria, S
Pretargeted dual-modality SPECT/fluorescence imaging of prostate cancer with an anti-TROP-2x anti-HSG bispecific antibody
2014-01-01 Lutje, S; Rijpkema, M; Mcbride, B; Sharkey, R; Goldenberg, D; Franssen, G; Eek, A; Helfrich, W; Oyen, W; Boerman, O
Tracking tumor associated macrophages in vivo with In-111-anti-F4/80
2014-01-01 Terry, Sya; Boermani, Oc; Gerritsi, D; Metselaar, J; Lehmann, S; Oyen, W; Gerdes, C; Abiraj, K
AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS.
2019-01-01 Oliviero, B; Donadon, M; Soldani, C; Franceschini, B; Torzilli, G; Maestri, M; Varchetta, S; Mele, D; Pedrazzoli, P; Mondelli, Mu; Mantovani, S
Effect of respiratory gated positron emission tomography on clinical staging and management of lung cancer
2015-01-01 Grootjans, W; Hermsen, R; Visser, E; Oyen, W; de Geus-Oei, Lf
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Longitudinal imaging of transplanted islets in a rat model with SPECT | 1-gen-2012 | Andralojc, Km; Brom, M; Joosten, L; Bos, Dl; Oyen, W; Boerman, Oc; Gotthardt, M | |
| XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY | 1-gen-2019 | Hurle, R; Saita, A; Lazzeri, M; Casale, P; Buffi, N; Lughezzani, G; Fasulo, V; Bevilacqua, G; Paciotti, M; Domanico, L; Maffei, D; Pasini, L; Guazzoni, G | |
| Image quality of U-SPECT-II collimators using an adapted NEMA phantom | 1-gen-2012 | Meeuwis, Apw; van der Have, F; Beekman, Fj; Oyen, W; Boerman, Oc; Visser, Ep | |
| Non-invasive determination of the beta cell mass by SPECT with In-111-DTPA-exendin-3 in a rat model for spontaneous type 1 diabetes | 1-gen-2012 | Brom, M; Bos, D; Visser, J; Joosten, L; Peeters, H; Oyen, W; Gotthardt, M; Boerman, O | |
| Diagnostic biological imaging of early relapse | 1-gen-2013 | Oyen, W | |
| Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules | 1-gen-2013 | Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, L | |
| In-111-exendin for non-invasive quantification of beta cell mass in patients with type 1 diabetes and healthy controls | 1-gen-2013 | van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cj; Boerman, Oc; Gotthardt, M | |
| LAPAROSCOPIC PARTIAL NEPHRECTOMY AFTER PREVIOUS IPSILATERAL RENAL PROCEDURES | 1-gen-2015 | Seveso, M; Castaldo, L; Hurle, R; Taverna, G; Lazzeri, M; Pasini, L; Buffi, Nm; Lughezzani, G; Casale, P; De Zorzi, Sz; Benetti, A; Guazzoni, G | |
| DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER | 1-gen-2019 | Maffei, D; Paciotti, M; Lazzeri, M; Colombo, P; Fasulo, V; Domanico, L; Casale, P; Saita, A; Hurle, R; Buffi, N; Guazzoni, G; Lughezzani, G | |
| Factor V Leiden is associated with premature myocardial infarction | 1-gen-2008 | Peyvandi, F.; Spreafico, M.; Foco, L.; Bernardinelli, L.; Duga, S.; Asselta, R.; Ardissino, D.; Kathiresan, S.; Merlini, P. A.; Mannucci, P. M. | |
| A mutational chip to detect TP53, CDKN2A and FAT1 mutations in circulating cell free-DNA of head and neck squamous cell carcinoma patients:a pilot study | 1-gen-2019 | Ganci, F.; Spinella, F.; Cottone, G.; Cotroneo, E.; Nuccitelli, A.; Biroccio, A.; Sacconi, A.; Manciocco, V.; Pallocca, M.; Rollo, F.; Covello, R.; Benevolo, M.; Spriano, G; Fiorentino, F.; Blandino, G. | |
| Predictive role of peritumoral CD3+infiltration and neutrophil to lymphocyte ratio on overall survial in pateints affected by colorectal liver metastases treated with chemotherapy and surgery. | 1-gen-2018 | Cimino, M; Donadon, M; Mavilio, D; Di Tommaso, L; Roncalli, M; Hudspeth, K; Sacerdote, C; Torzilli, G | |
| ONE STAGE HEPATECTOMY FOR MULTIPLE BILOBAR COLORECTAL LIVER METASTASES | 1-gen-2018 | Cimino, Mm; Procopio, F; Donadon, M; Vigano, L; Del Fabbro, D; Torzilli, G | |
| Effects of respiratory gated positron emission tomography on quantification of lesion volume and FDG uptake in clinical practice | 1-gen-2013 | Grootjans, W; de Geus-Oei, Lf; Meeuwis, Apw; Gotthardt, M; Oyen, W; Visser, Ep | |
| Anti-CEA antibody fragments labeled with [F-18]AlF for PET imaging of CEA-expressing tumors | 1-gen-2013 | Franssen, Gm; Laverman, P; Chatalic, Kls; Oyen, W; Sharkey, Rm; Goldenberg, Dm; Rossi, E; Mcbride, W; Boerman, Oc | |
| Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials | 1-gen-2014 | Ni, W; Vriens, D; de Geus-Oei, Lf; Oyen, W; Bengtsson, T; de Crespigny, A; Sanabria, S | |
| Pretargeted dual-modality SPECT/fluorescence imaging of prostate cancer with an anti-TROP-2x anti-HSG bispecific antibody | 1-gen-2014 | Lutje, S; Rijpkema, M; Mcbride, B; Sharkey, R; Goldenberg, D; Franssen, G; Eek, A; Helfrich, W; Oyen, W; Boerman, O | |
| Tracking tumor associated macrophages in vivo with In-111-anti-F4/80 | 1-gen-2014 | Terry, Sya; Boermani, Oc; Gerritsi, D; Metselaar, J; Lehmann, S; Oyen, W; Gerdes, C; Abiraj, K | |
| AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS. | 1-gen-2019 | Oliviero, B; Donadon, M; Soldani, C; Franceschini, B; Torzilli, G; Maestri, M; Varchetta, S; Mele, D; Pedrazzoli, P; Mondelli, Mu; Mantovani, S | |
| Effect of respiratory gated positron emission tomography on clinical staging and management of lung cancer | 1-gen-2015 | Grootjans, W; Hermsen, R; Visser, E; Oyen, W; de Geus-Oei, Lf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2151
Data di pubblicazione
- 2020 - 2026113
- 2010 - 20191340
- 2000 - 2009587
- 1990 - 1999110
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng794
- ita24
- und6
Accesso al fulltext
- no fulltext2098
- reserved51
- open2